You are here: Industry Insights > GSK

News List

GSK receives FDA approval for a new self-injectable formulation of Benlysta cphi-online
July 25, 2017
The approval marks the first subcutaneous self-injection treatment option for patients with systemic lupus erythematosus.
GSK continues restructure by axing £350m Cumbria plant plans pharmafile
July 24, 2017
UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its pharmaceutical product line....
GSK to invest additional £140m at UK manufacturing sites pharmaceutical-technology
July 21, 2017
GlaxoSmithKline (GSK) is set to invest more than £140m at its production facilities in the UK to improve the efficiency and competitiveness of its manufacturing network.
GSK to cut 320 jobs amid manufacturing revamp pharmatimes
July 21, 2017
GlaxoSmithKline is trimming its UK workforce by around 320 under a shake-up of its manufacturing network in the country, in a move designed to boost efficacy and competitiveness.
GSK Ships 2017-18 Seasonal Influenza Vaccines for US Market americanpharmaceuticalreview
July 18, 2017
GSK has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research.
GSK ships 2017-18 seasonal influenza vaccines for US market cphi-online
July 18, 2017
Company expects to supply up to 40 million doses across both vaccines for the US market in the 2017-18 season.
Could a MenB vaccine protect against gonorrhea? GSK wants to find out fiercepharma
July 14, 2017
Health authorities using a meningitis B shot in a mass vaccination campaign in New Zealand recently found a joyfully surprising byproduct—the vaccine might also offer protection against gonorrhea. Now, GlaxoSmithKline is planning to explore the potential
GSK to invest Rs 1,000 cr in Karnataka expressbpd
July 13, 2017
The drug major will also upgrade its existing Nashik facility
Immunocore and GSK pick third cancer immunotherapy target pharmaphorum
July 05, 2017
Immunocore, one of UK biotech’s brightest hopes, has selected a third target as part of its immuno-oncology partnership with GlaxoSmithKline.
GSK selects third oncology target in discovery partnership with Immunocore pharmaceutical-technology
July 05, 2017
UK-based firm GlaxoSmithKline (GSK) has selected a third target as part of its ongoing oncology discovery partnership with Immunocore for multiple novel targets not addressable with antibody-based technologies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page